---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248695129.md"
description: "ZHEJIANG ZHENYUAN stated on the interactive platform that the innovative new drug for cancer pain treatment is still in the exploratory research stage and there are no plans for market launch at this time"
datetime: "2025-07-16T01:10:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248695129.md)
  - [en](https://longbridge.com/en/news/248695129.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248695129.md)
---

# 

ZHEJIANG ZHENYUAN stated on the interactive platform that the innovative new drug for cancer pain treatment is still in the exploratory research stage and there are no plans for market launch at this time

### Related Stocks

- [000705.CN](https://longbridge.com/en/quote/000705.CN.md)

## Related News & Research

- [2 magnificent stocks to buy that are near 52-week lows](https://longbridge.com/en/news/286986937.md)
- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [China's top flash-memory chipmaker YMTC begins pre-IPO coaching talks with investment bank](https://longbridge.com/en/news/286879811.md)
- [CXMT Revenue Surges 700% Ahead of Planned China IPO](https://longbridge.com/en/news/286807461.md)
- [US State Secy Marco Rubio to visit India from May 23-26 ahead of Quad meet](https://longbridge.com/en/news/286984473.md)